Castration-resistant Prostate Cancer

Showing 26 - 50 of 76

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Prostate Cancer Metastatic, Castration-resistant Prostate Cancer Trial in Worldwide (Docetaxel in Parenteral Dosage Form,

Completed
  • Prostate Cancer Metastatic
  • Castration-resistant Prostate Cancer
  • Detroit, Michigan
  • +27 more
Feb 7, 2022

Prostate Cancer, Castration-Resistant Prostate Cancer Trial in Aurora (Transdermal Testosterone, Standard of Care, Enzalutamide)

Active, not recruiting
  • Prostate Cancer
  • Castration-Resistant Prostate Cancer
  • Transdermal Testosterone
  • Standard of Care, Enzalutamide
  • Aurora, Colorado
    University of Colorado Hospital
Jan 31, 2022

Next Generation PET and Liquid Biopsy to Monitor mCRPC Treated

Recruiting
  • Prostate Cancer
  • +2 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 27, 2021

Castration-resistant Prostate Cancer Trial in Boston (Crizotinib, Enzalutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 5, 2022

Prostate Cancer Metastatic, Castration-resistant Prostate Cancer Trial in Belfast (Exercise)

Recruiting
  • Prostate Cancer Metastatic
  • Castration-resistant Prostate Cancer
  • Exercise
  • Belfast, United Kingdom
    Northern Ireland Cancer Centre, Belfast City Hospital
Nov 30, 2021

Castration-resistant Prostate Cancer, Metastatic Prostate Cancer, Prostate Cancer Trial in San Francisco, Baltimore, Boston

Active, not recruiting
  • Castration-resistant Prostate Cancer
  • +2 more
  • San Francisco, California
  • +2 more
Nov 16, 2021

Castration-resistant Prostate Cancer Trial in Netherlands (ModraDoc006/r)

Completed
  • Castration-resistant Prostate Cancer
  • Amsterdam, Netherlands
  • +3 more
Oct 18, 2021

Metastatic Prostate Cancer, Castration-resistant Prostate Cancer Trial in Montréal (Darolutamide (BAY1841788), SBRT)

Recruiting
  • Metastatic Prostate Cancer
  • Castration-resistant Prostate Cancer
  • Darolutamide (BAY1841788)
  • SBRT
  • Montréal, Quebec, Canada
    Sir Mortimer JGH
Sep 20, 2021

Castration-resistant Prostate Cancer Trial in Osaka (Enzalutamide, Flutamide)

Completed
  • Castration-resistant Prostate Cancer
  • Osaka, Japan
    Osaka City University Graduate School of Medicine
Sep 8, 2021

Castration-resistant Prostate Cancer, Bone Metastases Trial in Osaka (Ra-223 in combination with enzalutamide)

Active, not recruiting
  • Castration-resistant Prostate Cancer
  • Bone Metastases
  • Ra-223 in combination with enzalutamide
  • Osaka, Japan
    Osaka City University Graduate School of Medicine
Sep 8, 2021

Castration-resistant Prostate Cancer, Metastasis Trial in France (Carboplatin)

Terminated
  • Castration-resistant Prostate Cancer
  • Metastasis
  • Caen, France
  • +3 more
Apr 28, 2021

Castration-resistant Prostate Cancer, Metastatic Cancer, Bone Metastases Trial in Ireland (Xgeva, Xtandi)

Suspended
  • Castration-resistant Prostate Cancer
  • +2 more
  • Galway, Connacht, Ireland
  • +6 more
Apr 23, 2021

Castration-resistant Prostate Cancer, Androgen Deprivation Therapy Trial in Chapel Hill, Winston-Salem (Home-based exercise)

Completed
  • Castration-resistant Prostate Cancer
  • Androgen Deprivation Therapy
  • Home-based exercise
  • Chapel Hill, North Carolina
  • +1 more
Mar 26, 2021

Oligoprogressive, Castration-Resistant Prostate Cancer Trial in Toronto (Stereotactic Body Radiation Therapy (SABR))

Recruiting
  • Oligoprogressive
  • Castration-Resistant Prostate Cancer
  • Stereotactic Body Radiation Therapy (SABR)
  • Toronto, Ontario, Canada
    Odette Cancer Centre
Apr 9, 2021

Castration-resistant Prostate Cancer Trial in Wuxi (Coenzyme A Combined With Abiraterone, Abiraterone)

Recruiting
  • Castration-resistant Prostate Cancer
  • Wuxi, Jiangsu, China
    Jiangnan University
Apr 8, 2021

Patients With Castration-Resistant Prostate Cancer (CRPC)

Completed
  • Prostate Cancer
  • +2 more
    • Homewood, Alabama
    • +147 more
    Mar 2, 2021

    CTC, Free DNA, Stem Cells and EMT-related Antigens as Biomarkers

    Active, not recruiting
    • Prostate Cancer
    • +3 more
    • blood and FFPE sample collection
    • Ancona, AN, Italy
    • +8 more
    Feb 25, 2021

    Castration-resistant Prostate Cancer Trial in Fairfax (Calcitriol, Ketoconazole, Hydrocortisone)

    Terminated
    • Castration-resistant Prostate Cancer
    • Calcitriol, Ketoconazole, Hydrocortisone
    • Fairfax, Virginia
      Inova Schar Cancer Institute
    Jan 19, 2021

    Prostate Cancer, Castration-resistant Prostate Cancer Trial in Shanghai (SHR3680, SHR2554)

    Terminated
    • Prostate Cancer
    • Castration-resistant Prostate Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Feb 2, 2021

    Castration-resistant Prostate Cancer Trial in Praha (DCVac/PCa, Cyclophosphamide)

    Terminated
    • Castration-resistant Prostate Cancer
    • Praha, Czechia
      Fakultní nemocnice v Motole
    Jan 27, 2021

    Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

    Completed
    • Castration-resistant Prostate Cancer
    • Aichi, Japan
    • +46 more
    Dec 22, 2020

    Castration-resistant Prostate Cancer, Metastatic Breast Cancer, Uterine Leiomyoma Trial in Worldwide (LFA102)

    Completed
    • Castration-resistant Prostate Cancer
    • +2 more
    • Boston, Massachusetts
    • +8 more
    Dec 16, 2020

    Castration-resistant Prostate Cancer Trial in Worldwide (BEZ235, BKM120)

    Completed
    • Castration-resistant Prostate Cancer
    • Los Angeles, California
    • +9 more
    Dec 6, 2020